Dumont & Blake Investment Advisors LLC Sells 709 Shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Dumont & Blake Investment Advisors LLC lessened its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJPFree Report) by 3.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,765 shares of the company’s stock after selling 709 shares during the quarter. Dumont & Blake Investment Advisors LLC’s holdings in Invesco Pharmaceuticals ETF were worth $1,504,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of PJP. UBS Group AG grew its stake in Invesco Pharmaceuticals ETF by 132.2% during the 3rd quarter. UBS Group AG now owns 92,123 shares of the company’s stock valued at $6,667,000 after purchasing an additional 52,455 shares during the last quarter. Bank of America Corp DE boosted its position in Invesco Pharmaceuticals ETF by 78.4% in the fourth quarter. Bank of America Corp DE now owns 97,302 shares of the company’s stock valued at $7,648,000 after buying an additional 42,755 shares during the last quarter. Wells Fargo & Company MN increased its holdings in Invesco Pharmaceuticals ETF by 102.3% in the 2nd quarter. Wells Fargo & Company MN now owns 61,645 shares of the company’s stock worth $4,662,000 after buying an additional 31,171 shares during the period. Cambridge Investment Research Advisors Inc. increased its holdings in Invesco Pharmaceuticals ETF by 206.0% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 41,273 shares of the company’s stock worth $2,987,000 after buying an additional 27,786 shares during the period. Finally, Citadel Advisors LLC purchased a new position in Invesco Pharmaceuticals ETF during the 3rd quarter worth approximately $1,408,000.

Invesco Pharmaceuticals ETF Trading Up 0.1 %

Shares of PJP stock traded up $0.06 during trading hours on Wednesday, hitting $78.67. The company’s stock had a trading volume of 13,498 shares, compared to its average volume of 26,745. The stock has a market cap of $296.59 million, a PE ratio of 14.11 and a beta of 0.66. Invesco Pharmaceuticals ETF has a 12-month low of $67.75 and a 12-month high of $80.65. The company has a 50 day moving average of $77.80 and a 200 day moving average of $74.53.

Invesco Pharmaceuticals ETF Profile

(Free Report)

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.

Featured Stories

Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJPFree Report).

Institutional Ownership by Quarter for Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.